We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-6.94%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$36B
AUM Growth
-$4.08B
Cap. Flow
-$447M
Cap. Flow %
-1.24%
Top 10 Hldgs %
13.36%
Holding
818
New
100
Increased
225
Reduced
326
Closed
109

Sector Composition

Rank Sector Weight
1 Healthcare 16.21%
2 Technology 12.34%
3 Financials 12.29%
4 Industrials 10.3%
5 Consumer Staples 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEN
601
DELISTED
Genesis Healthcare, Inc.
GEN
$5.52M 0.02%
900,000
+790,846
+725% +$5.36M
JBTM
602
JBT Marel
JBTM
$7.21B
$5.49M 0.02%
+143,484
New +$5.2M
MTEM
603
DELISTED
Molecular Templates, Inc.
MTEM
$5.29M 0.01%
7,879
+606
+8% +$431K
OLLI icon
604
Ollie's Bargain Outlet
OLLI
$4.44B
$5.25M 0.01%
+325,000
New +$6.02M
RVNC
605
DELISTED
Revance Therapeutics, Inc.
RVNC
$5.23M 0.01%
+175,773
New +$5.34M
ITGR icon
606
Integer Holdings
ITGR
$4.12B
$5.19M 0.01%
100,834
-36,291
-26% -$1.81M
GPK icon
607
Graphic Packaging
GPK
$3.17B
$5.12M 0.01%
400,000
+200,000
+100% +$2.85M
SGMO
608
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$5.08M 0.01%
900,000
-450,000
-33% -$3.71M
SXT icon
609
Sensient Technologies
SXT
$5.26B
$5M 0.01%
+81,484
New +$5.36M
FLR icon
610
Fluor
FLR
$7.01B
$4.89M 0.01%
115,479
+81,361
+238% +$3.82M
KYTH
611
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$4.87M 0.01%
+65,000
New +$4.85M
EVH icon
612
Evolent Health
EVH
$348M
$4.79M 0.01%
300,000
-100,000
-25% -$1.95M
URBN icon
613
Urban Outfitters
URBN
$6.35B
$4.71M 0.01%
160,300
+9,907
+7% +$318K
GI
614
DELISTED
EndoChoice Holdings, Inc.
GI
$4.58M 0.01%
403,250
+78,250
+24% +$1.23M
NEOS
615
DELISTED
Neos Therapeutics, Inc
NEOS
$4.52M 0.01%
+215,000
New +$4.74M
TFCFA
616
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$4.48M 0.01%
166,031
-1,366,498
-89% -$40.8M
TDOC icon
617
Teladoc Health
TDOC
$1.22B
$4.46M 0.01%
+200,000
New +$5.4M
PMC
618
DELISTED
PharMerica Corporation
PMC
$4.27M 0.01%
150,000
-50,000
-25% -$1.68M
GKOS icon
619
Glaukos
GKOS
$9.83B
$4.23M 0.01%
175,000
CORV
620
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$4.22M 0.01%
500,000
ADAP
621
DELISTED
Adaptimmune Therapeutics
ADAP
$4.19M 0.01%
350,000
+50,000
+17% +$706K
GMED icon
622
Globus Medical
GMED
$10.7B
$4.13M 0.01%
200,000
TRNX
623
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$4.08M 0.01%
200,000
-150,000
-43% -$3.61M
PEN icon
624
Penumbra
PEN
$12.7B
$4.01M 0.01%
+100,000
New +$4.04M
BLUE
625
DELISTED
bluebird bio
BLUE
$3.96M 0.01%
3,574
+46
+1% +$83.9K

Similar funds

Adage Capital Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Adage Capital Partners held 818 positions worth $36B, down 10% from $40.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Adage Capital Partners's Q3 2015 filing shows 100 new, 225 increased, 326 reduced and 109 closed positions. Its largest new stake was Citizens Financial Group: 3,800,000 shares worth $90.7M. The largest sale was FAMILY DOLLAR STORES, an estimated $260M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

  • Adage Capital Partners's largest Q3 2015 buy was Citizens Financial Group: 3,800,000 shares worth $90.7M.
  • Adage Capital Partners added most to PRECISION CASTPARTS CORP in Q3 2015, an estimated $243M increase.
  • Adage Capital Partners's biggest Q3 2015 reduction was RTX Corp, cutting an estimated $217M.
  • Adage Capital Partners fully exited FAMILY DOLLAR STORES in Q3 2015, selling an estimated $260M.
  • Adage Capital Partners's ten largest holdings make up 13% of its $36B portfolio in Q3 2015.
  • Adage Capital Partners opened 100 new positions and closed 109 in Q3 2015.
  • Adage Capital Partners's portfolio value fell 10% quarter-over-quarter to $36B.

Based on Adage Capital Partners's 13F filing for Q3 2015, filed 16 Nov 2015.